• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含双功能单氨基酸螯合物的[三氯化铼(III)]核心配合物。

[Re(III)Cl(3)] core complexes with bifunctional single amino acid chelates.

作者信息

Banerjee Sangeeta Ray, Wei Lihui, Levadala Murali K, Lazarova Neva, Golub Vladimir O, O'Connor Charles J, Stephenson Karin A, Valliant John F, Babich John W, Zubieta Jon

机构信息

Department of Chemistry, Syracuse University, Syracuse, NY 13244, USA.

出版信息

Inorg Chem. 2002 Nov 4;41(22):5795-802. doi: 10.1021/ic020391d.

DOI:10.1021/ic020391d
PMID:12401085
Abstract

The reactions of the Re(V) starting material [ReO(PPh(3))(2)Cl(3)] with ligands of the type XN(Y)Z [X = Y = 2-pyridylmethyl, Z = -CH(2)CO(2)Et (L(1)Et), -CH(2)CH(2)CO(2)Et (L(2)Et), -CH(2)CH(2)CH(2)CH(2)CH(NHCO(2)Bu(t))CO(2)H (L(3)H); X = 2-pyridylmethyl, Y = 2-(1-methylimidazolyl)methyl, Z = -CH(2)CO(2)Et (L(4)Et)] yielded the Re(III) trichloride complexes of the type [ReCl(3)(L(n)R)]. The complexes are mononuclear, paramagnetic species with a facial geometry of the chloride ligands. The nitrogen donors of the tridentate L(n)()R ligands complete the distorted octahedral coordination spheres of the complexes. Crystal data: [ReCl(3)(L(1)Et)] (1), monoclinic, C2/m, a = 16.088(3) A, b = 9.980(2) A, c = 12.829(2) A, beta = 91.384(3) degrees, Z = 4, D(calc) = 1.967 g/cm(-)(3); [ReCl(3)(L(4)Et)] (4), monoclinic, C2/c, a = 22.880(1) A, b = 7.4926(4) A, c = 22.560(1) A, beta = 94.186(1) degrees, Z = 8, D(calc) = 2.001 g/cm(-3).

摘要

Re(V)起始原料[ReO(PPh(3))(2)Cl(3)]与XN(Y)Z类型的配体[X = Y = 2 - 吡啶甲基,Z = -CH(2)CO(2)Et (L(1)Et),-CH(2)CH(2)CO(2)Et (L(2)Et),-CH(2)CH(2)CH(2)CH(2)CH(NHCO(2)Bu(t))CO(2)H (L(3)H);X = 2 - 吡啶甲基,Y = 2 - (1 - 甲基咪唑基)甲基,Z = -CH(2)CO(2)Et (L(4)Et)]反应,生成了[ReCl(3)(L(n)R)]类型的Re(III)三氯化物配合物。这些配合物是单核、顺磁性物种,其氯配体具有面式几何构型。三齿L(n)()R配体的氮供体完善了配合物扭曲的八面体配位球。晶体数据:[ReCl(3)(L(1)Et)] (1),单斜晶系,C2/m,a = 16.088(3) Å,b = 9.980(2) Å,c = 12.829(2) Å,β = 91.384(3)°,Z = 4,D(calc) = 1.967 g/cm(-)(3);[ReCl(3)(L(4)Et)] (4),单斜晶系,C2/c,a = 22.880(1) Å,b = 7.4926(4) Å,c = 22.560(1) Å,β = 94.186(1)°,Z = 8,D(calc) = 2.001 g/cm(-3)。

相似文献

1
[Re(III)Cl(3)] core complexes with bifunctional single amino acid chelates.含双功能单氨基酸螯合物的[三氯化铼(III)]核心配合物。
Inorg Chem. 2002 Nov 4;41(22):5795-802. doi: 10.1021/ic020391d.
2
Bifunctional single amino acid chelates for labeling of biomolecules with the [Tc(CO)(3)](+) and [Re(CO)(3)](+) cores. Crystal and molecular structures of [ReBr(CO)(3)(H(2)NCH(2)C(5)H(4)N)], [Re(CO)(3)[(C(5)H(4)NCH(2))(2)NH]]Br, [Re(CO)(3)[(C(5)H(4)NCH(2))(2)NCH(2)CO(2)H]]Br, [Re(CO)(3)[X(Y)NCH(2)CO(2)CH(2)CH(3)]]Br (X = Y = 2-pyridylmethyl; X = 2-pyridylmethyl, Y = 2-(1-methylimidazolyl)methyl; X = Y = 2-(1-methylimidazolyl)methyl), [ReBr(CO)(3)[(C(5)H(4)NCH(2))NH(CH(2)C(4)H(3)S)]], and [Re(CO)(3)[(C(5)H(4)NCH(2))N(CH(2)C(4)H(3)S)(CH(2)CO(2))]].用于用[Tc(CO)(3)]⁺和[Re(CO)(3)]⁺核心标记生物分子的双功能单氨基酸螯合物。[ReBr(CO)(3)(H₂NCH₂C₅H₄N)]、[Re(CO)(3)[(C₅H₄NCH₂)₂NH]]Br、[Re(CO)(3)[(C₅H₄NCH₂)₂NCH₂CO₂H]]Br、[Re(CO)(3)[X(Y)NCH₂CO₂CH₂CH₃]]Br(X = Y = 2-吡啶基甲基;X = 2-吡啶基甲基,Y = 2-(1-甲基咪唑基)甲基;X = Y = 2-(1-甲基咪唑基)甲基)、[ReBr(CO)(3)[(C₅H₄NCH₂)NH(CH₂C₄H₃S)]]和[Re(CO)(3)[(C₅H₄NCH₂)N(CH₂C₄H₃S)(CH₂CO₂)]]的晶体和分子结构
Inorg Chem. 2002 Dec 2;41(24):6417-25. doi: 10.1021/ic020476e.
3
Synthesis and characterization of novel 99gTc(V) and Re(V) complexes with water-soluble tetraaza diamido dipyridino ligands: single-crystal X-ray structural investigations of mono- and dinuclear complexes.新型99gTc(V)和Re(V)与水溶性四氮杂二酰胺二吡啶配体配合物的合成与表征:单核和双核配合物的单晶X射线结构研究
Inorg Chem. 2003 May 5;42(9):2960-7. doi: 10.1021/ic020434q.
4
Synthesis and characterization of rhenium(V) oxo complexes with N-[N-(3-diphenylphosphinopropionyl)glycyl]cysteine methyl ester. X-ray crystal structure of (ReO[Ph(2)P(CH(2))(2)C(O)-Gly-Cys-OMe(P,N,N,S)]).含N-[N-(3-二苯基膦基丙酰基)甘氨酰]半胱氨酸甲酯的铼(V)氧配合物的合成与表征。(ReO[Ph(2)P(CH(2))(2)C(O)-Gly-Cys-OMe(P,N,N,S)])的X射线晶体结构
Inorg Chem. 2003 Feb 24;42(4):950-9. doi: 10.1021/ic025859r.
5
Rhenium tricarbonyl core complexes of thymidine and uridine derivatives.胸苷和尿苷衍生物的三羰基铼核心配合物
Inorg Chem. 2005 Apr 4;44(7):2198-209. doi: 10.1021/ic048301n.
6
Re(V) and Re(III) complexes with sal2phen and triphenylphosphine: rearrangement, oxidation and reduction.Re(V) 和 Re(III) 配合物与 sal2phen 和三苯基膦:重排、氧化和还原。
Dalton Trans. 2011 Jan 7;40(1):269-76. doi: 10.1039/c0dt00993h. Epub 2010 Nov 15.
7
Technetium and rhenium in five-coordinate symmetrical and dissymmetrical nitrido complexes with alkyl phosphino-thiol ligands. Synthesis and structural characterization.含烷基膦硫醇配体的五配位对称和不对称氮基配合物中的锝和铼。合成与结构表征。
Inorg Chem. 2008 Dec 15;47(24):11972-83. doi: 10.1021/ic801436d.
8
A mono-diazenide complex from perrhenate: toward a new core for rhenium radiopharmaceuticals.一种来自高铼酸盐的单重氮化合物配合物:迈向铼放射性药物的新核心。
Inorg Chem. 2003 Feb 24;42(4):929-31. doi: 10.1021/ic025995w.
9
Carboranes as ligands for the preparation of organometallic Tc and Re Radiopharmaceuticals. Synthesis of [M(CO)(3)(eta-2,3-C(2)B(9)H(11))](-) and rac-[M(CO)(3)(eta-2-R-2,3-C(2)B(9)H(10))](-) (M = Re, (99)Tc; R = CH(2)CH(2)CO(2)H) from [M(CO)(3)Br(3)](2-).碳硼烷作为制备有机金属锝和铼放射性药物的配体。由[M(CO)₃Br₃]²⁻合成[M(CO)₃(η-2,3-C₂B₉H₁₁)]⁻和rac-[M(CO)₃(η-2-R-2,3-C₂B₉H₁₀)]⁻(M = Re,⁹⁹Tc;R = CH₂CH₂CO₂H)
Inorg Chem. 2002 Feb 25;41(4):628-30. doi: 10.1021/ic0156285.
10
Rhenium(V) and technetium(V) nitrido complexes with mixed tridentate π-donor and monodentate π-acceptor ligands.五铼(V)和五锝(V)亚硝络合物与混合的三齿π-给体和单齿π-受体配体。
Inorg Chem. 2012 Mar 5;51(5):3130-7. doi: 10.1021/ic202605z. Epub 2012 Feb 10.

引用本文的文献

1
Novel rhenium(III, IV, and V) tetradentate N2O2 Schiff base mononuclear and dinuclear complexes.新型铼(III、IV 和 V)四齿 N2O2 希夫碱单核和双核配合物。
Dalton Trans. 2013 Aug 28;42(32):11614-25. doi: 10.1039/c3dt51198g. Epub 2013 Jul 4.
2
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer.优化基于肽的前列腺特异性抗原(PSA)抑制剂作为前列腺癌的靶向成像剂。
Bioorg Med Chem. 2009 Jul 15;17(14):4888-93. doi: 10.1016/j.bmc.2009.06.012. Epub 2009 Jun 13.
3
Development of an optimized activatable MMP-14 targeted SPECT imaging probe.
一种优化的可激活基质金属蛋白酶-14靶向单光子发射计算机断层扫描成像探针的研发。
Bioorg Med Chem. 2009 Jan 15;17(2):653-9. doi: 10.1016/j.bmc.2008.11.078. Epub 2008 Dec 6.
4
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).前列腺特异性膜抗原(PSMA)的锝-99m和铼标记抑制剂的合成与评价
J Med Chem. 2008 Aug 14;51(15):4504-17. doi: 10.1021/jm800111u. Epub 2008 Jul 19.